Pharmacokinetics of oxytetracycline and therapeutic implications in veal calves. 1982

D Schifferli, and R L Galeazzi, and J Nicolet, and M Wanner

Pharmacokinetic parameters of oxytetracycline were analysed in healthy preruminant veal calves after intravenous, intramuscular and oral administration. The serum half-lives in the beta-elimination phase of both 10% and 20% solutions after i.v. injection of 10 mg/kg were similar (7.07 +/- 1.36 h and 7.16 +/- 1.17 h, mean +/- SD), whereas the total body clearance and the apparent volume of distribution were higher for the 20% solution. Serum concentrations above 0.5 microgram/ml were maintained with both formulations during 12-24 h but were only above 4 micrograms/ml to 5 h. Intramuscular administration of the 20% solution gave a complete absorption with two rate constants of absorption, a faster (t1/2 alpha 1 = 0.27 h) and a slower one (t1/2 alpha 2 = 10.90 h) responsible for the delayed elimination half-life after this route of application (t1/2 beta = 9.83 +/- 1.35 h). Mean serum concentrations reached a maximum level of 3.01 +/- 0.72 micrograms/ml at 4.01 +/- 2.84 h and decreased to 0.5 microgram/ml between 12 and 24 h. 50 mg/kg given orally with a milk replacer were found to have a mean bioavailability of 46.35%. A mean serum peak level of 4.99 +/- 1.37 micrograms/ml was achieved at 9.16 +/- 1.99 h and the mean concentration was still above 0.5 microgram/ml after 48 h. The elimination half-life (t1/2 beta = 10.66 +/- 3.15 h) reflected the slow absorption step (t1/2 alpha 2 = 10.15 h) following that responsible for the initial faster absorption (t1/2 alpha 1 = 1.99 h). Comparison of the area under the serum curves gave mean values of 117% for tetracycline and of 53% for chlortetracycline relative to oxytetracycline (arbitrarily fixed at 100%) after identical oral dosage of the three tetracyclines. We also propose and discuss a dosage schedule based on minimal inhibitory concentrations of different susceptible pathogens.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D010118 Oxytetracycline A TETRACYCLINE analog isolated from the actinomycete STREPTOMYCES RIMOSUS and used in a wide variety of clinical conditions. Hydroxytetracycline,Bisolvomycin,Geomycin,Oxyterracin,Oxyterracine,Oxytetracid,Oxytetracycline Anhydrous,Oxytetracycline Calcium,Oxytetracycline Dihydrate,Oxytetracycline Hydrochloride,Oxytetracycline Monohydrochloride,Oxytetracycline Sulfate (2:1),Oxytetracycline, (4a beta,5 beta,5a beta,12a beta)-Isomer,Oxytetracycline, (5 beta)-Isomer,Oxytetracycline, Anhydrous,Oxytetracycline, Calcium (1:1) Salt,Oxytetracycline, Disodium Salt, Dihydrate,Oxytetracycline, Sodium Salt,Terramycin
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002418 Cattle Diseases Diseases of domestic cattle of the genus Bos. It includes diseases of cows, yaks, and zebus. Bovine Diseases,Bovine Disease,Cattle Disease,Disease, Bovine,Disease, Cattle,Diseases, Bovine,Diseases, Cattle
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

D Schifferli, and R L Galeazzi, and J Nicolet, and M Wanner
January 1992, The British veterinary journal,
D Schifferli, and R L Galeazzi, and J Nicolet, and M Wanner
December 1986, Journal of veterinary pharmacology and therapeutics,
D Schifferli, and R L Galeazzi, and J Nicolet, and M Wanner
September 1993, Journal of toxicology and environmental health,
D Schifferli, and R L Galeazzi, and J Nicolet, and M Wanner
June 2016, American journal of veterinary research,
D Schifferli, and R L Galeazzi, and J Nicolet, and M Wanner
November 1991, Journal of animal science,
D Schifferli, and R L Galeazzi, and J Nicolet, and M Wanner
January 1985, Veterinarno-meditsinski nauki,
D Schifferli, and R L Galeazzi, and J Nicolet, and M Wanner
January 1987, The veterinary quarterly,
D Schifferli, and R L Galeazzi, and J Nicolet, and M Wanner
June 1990, Journal of veterinary pharmacology and therapeutics,
D Schifferli, and R L Galeazzi, and J Nicolet, and M Wanner
March 1987, Journal of veterinary pharmacology and therapeutics,
D Schifferli, and R L Galeazzi, and J Nicolet, and M Wanner
August 2013, Journal of veterinary pharmacology and therapeutics,
Copied contents to your clipboard!